Speaking engagements

Coming up…

Jane Barlow at MedImpact 2020 in Carlsbad, March 23–25

Mark Trusheim at Hanson-Wade 4th Annual Gene Therapy for Rare Disorders, March 30 in Boston

Mark Trusheim at Eye for Pharma Philadelphia 2020, April 15–16

Jane Barlow at National Cooperative Rx Annual Meeting, April 21 in Madison

Mark Trusheim at The Global Orphan Drug Congress 2020, May 1 in Oxon Hill, Maryland

February 2020

February 21, Mark Trusheim participated in the 2020 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR in Orlando.

February 13, Mark Trusheim participated in the FasterCures Data Collection Challenges Workshop in Washington, DC.

February 7, Danielle Rollmann attended the Medicaid Innovations Forum in Orlando and represented FoCUS in a panel titled Guiding the Future of Pharmacy Benefits: Adapting to Gene Therapy and Ultra High-Cost Drugs to Make Leading-edge Care Affordable.

February 6–7 Mark Trusheim spoke at the BCBSA/Aspen Institute Advanced Therapies event in Washington DC.

January 2020

On January 23, Mark Trusheim presented at Pfizer in New York City, and on January 29 he will participate in the MassBio Policy Breakfast in Boston.

December 2019

December 4, John Glasspool was on a panel with Rena Conti discussing The Science, Policy, and Potential of Cell and Gene Therapies at the Alliance for Health Policy 2019 Signature Series: Solving for Health event in Washington, DC. A video recording of the panel, with supplemental materials, is available online.

December 6, Mark Trusheim presented at the Brocher Foundation Value Creation in Precision Medicine workshop in Hermance, Switzerland.

December 7-9, Jonathan Salcedo presented a poster on The Total Direct Cost of Healthcare in the United States in Patients with Sickle Cell Disease: A Propensity Score Matched Analysis at the American Society of Hematology Annual Meeting in San Diego, California.

December 12, Jonathan Salcedo presented at CBI’s BioMAN 11th Annual Biomanufacturing Summit on Technology and Innovation for Sustainable Manufacturing of Advanced Therapy Medicinal Products in Cambridge, Massachusetts.

November 2019

Jane Barlow and Brendan Hayes presented “Novel Therapy Access Update: Structural Considerations” at Hemophilia CANEXTions in California on November 5.
 
Colin Young and Daniel Mytelka each had presentations at the American Society of Gene & Cell Therapy (ASGCT) Policy Summit on November 5 in Washington, DC. 
 
Daniel Mytelka was invited to participate in the prestigious Medicaid and CHIP Payment Advisory Commission Roundtable on November 6 in Washington, DC.
 
Mark Trusheim presented at the Financial Times Global Pharmaceutical & Biotechnology Conference in London on November 11–12, and he presented at the World Orphan Drug Congress, Europe 2019 in Barcelona on November 14

Danielle Rollmann presented “Cell & Gene Therapy Pipeline” at the Canadian Organization for Rare Disorders (CORD) Access to Innovation Conference on November 19 in Toronto.

John Glasspool spoke on a panel at the National Health Council’s Washington Representatives Retreat on November 21 in Annapolis, Maryland.

October 2019

Two of our team members were at the Association of Managed Care Practitioners (AMCP) Nexus in Maryland. Jane Barlow presented “Alternative Payment Models: Transitioning to Pay for Value” on October 30 and on October 31 Jonathan Salcedo had a poster presentation on “Pediatric Inpatient Costs of Select Orphan Conditions with Potential Gene Therapy Launches: A Cross-Sectional Analysis of 2016” which was based on the work for our May Research Brief. Jonathan, Susan Trieu, Réka Shinkle, and Jennifer Bulovic received the Bronze ribbon for their poster!

Mark Trusheim presented "Innovative Payment Models in Practice in U.S." for the event "Gene Therapy: A challenge for the National Health Service, an opportunity for patients" in Rome at the Giovanni Spadolini Library of the Senate of the Republic, Hall of Parliamentary Acts. On October 21 he and  Krishna Komanduri, MD participated in the Association of American Cancer Institutes' CAR-T Symposium panel "Exploring the Value and Cost-Effectiveness of CAR T-Cell Therapy" in Washington, DC, and October 29–30 he participated in DIA's "Master Protocol Workshop" in Bethesda, Maryland.

Jane Barlow participated in the workshop "Real World Evidence to Drive Acceptance and Uptake of Cell and Gene Therapy: Lessons and Best Practices" at Cell & Gene Therapy Meeting on the Mesa, on October 3.

FoCUS therapy pipeline projections were referenced in PwC's article "Gene therapies require advanced capabilities to succeed after approval" and Drug Channels's article "How Express Scripts Plans to Disrupt the Emerging Cell and Gene Therapy Channel"

September 2019

Mark Trusheim spoke at the Duke-Margolis Value-Based Payments Consortium conference on September 11, and the Financial Times Pharma Pricing and Value Summit on September 26. 

Jane Barlow and Colin Young each make presentations at the 2019 Managed Care Risk Association Annual Conference on September 17, and on September 25 Jane spoke at the Huron Consulting Group Cell and Gene Therapy Roundtable.

Casey Quinn spoke at the Cell and Gene Therapy Bioprocessing and Commercialization Conference on September 12 and at the FasterCures Patient Access to Cell & Gene Therapy Stakeholder Workshop on September 24. 

Jonathan Salcedo's abstract submission for the AMCP Nexus 2019 Poster Exhibition, “Pediatric Inpatient Costs of Select Orphan Conditions with Potential Gene Therapy Launches: A Cross-Sectional Analysis of 2016,” was selected for a Bronze ribbon.

June 2019

Mark Trusheim spoke at the Rare Disease Innovation and Partnering Summit, on a panel entitled, "Delve Into the Evolving Reimbursement Landscape and Developments in Payer Policy" on June 14 in Boston, Massachusetts. 

May 2019

Mark Trusheim speaks at ISPOR Annual Meeting
Trusheim spoke on the panel "Is Affordability Driving a Need to Revolutionize Drug Pricing?", which was moderated by Colleen M. Flood, F.R.S.C., Director, University of Ottawa Centre for Health Law, Policy and Ethics, Ottawa, ON, Canada, and also featured Muna Bhanji, RPh, Senior Vice President, Global Market Access, Merck; Meindert Boysen, PharmD, MSc, Director, Centre for Health Technology Evaluation, NICE, Manchester, UK; and Lou Garrison, PhD, Professor Emeritus, The Comparative Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle, WA, USA. 

April 2019

Casey Quinn at World Federation of Hemophilia gathering
Through its relationship with the National Hemophilia Foundation, FoCUS was invited to make a presentation on April 4th in Montreal at the World Federation of Hemophilia 2nd Gene Therapy Round Table. Research Advisor Casey Quinn presented on a panel about reimbursement and paying for gene therapies. (At the same meeting, FoCUS pipeline projections were shown by an FDA representative.) Quinn helped connect FoCUS to a wide range of people at the meeting including regulators, payers, developers, and of course patients, from the US and around the globe.

March 2019

FoCUS project members at Academy of Managed Care Pharmacy (AMCP) Annual Meeting
Jane Barlow, Terry Cothran, Paul Jeffrey, Susan Trieu, Ed Pezalla, and Kim Caldwell gave talks at the conference in late March in San Diego

FoCUS at the Hansen Wade 3rd Annual Gene Therapy for Rare Disorders conference
Michael Sherman, Mark Trusheim, Kevin Mayo, Marianne Hamilton Lopez, Brendan Hayes, and Colin Young participated in the three day conference in late March which focused exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market. Sherman and Trusheim each gave presentations; Mayo, Trusheim, and Hayes were in panel discussions; Hamilton Lopez led a workshop; and Young presented a poster, "Investing in a biotech revolution: analysis of clinical trials and financial investments in CAR-T and TCR therapies for the treatment of cancer".

October 2018

Dr Jane Barlow, Senior Advisor to FoCUS, delivered the address “How Curative, High-Cost Therapies Bring Challenges to the Reimbursement Landscape” at the Academy of Managed Care Pharmacy (AMCP) Nexus 2018 conference. Learn more and watch the recording

Send feedback

We want to know what works for you, and what doesn't. Please share your thoughts with us!

Subscribe to news

Join our mailing list to keep up to date on Paying for Cures news and events.